Related Experiment Videos

Novel antibiotics for the management of diabetic foot infections

Nesrene S Omar1, Mamdouh R El-Nahas, Jim Gray

  • 1Medical Microbiology & Immunology Department, Faculty of Medicine, Mansoura University, Egypt. nsromar@yahoo.com

International Journal of Antimicrobial Agents
|December 25, 2007
PubMed

Insights

Diabetic foot infections (DFI) present challenges due to rising antibiotic resistance, including MRSA. New antibiotics show promise for treating these complex skin infections, offering potential new therapeutic options.

Area of Science:

  • Infectious Diseases
  • Dermatology
  • Pharmacology

Background:

  • Diabetic foot infections (DFI) are a significant cause of illness and complications in diabetic patients.
  • Increasing multidrug resistance, including methicillin-resistant Staphylococcus aureus (MRSA) and extended-spectrum beta-lactamase-producing Gram-negative bacteria, complicates DFI treatment.
  • Emergence of novel antibiotics coincides with rising antimicrobial resistance in DFI pathogens.

Purpose of the Study:

  • To review the evidence for the efficacy of new antibiotic agents in treating skin and skin-structure infections (SSSIs).
  • To specifically evaluate the role of new antibiotics in managing diabetic foot infections (DFI).
  • To determine the potential place of these new agents in the therapeutic strategies for DFI.

Main Methods:

  • Literature review of existing evidence on new antibiotic efficacy in SSSIs.
  • Inclusion of data specifically pertaining to diabetic foot infections.
  • Analysis of antibiotic spectrum of activity and pharmacological properties relevant to DFI.

Main Results:

  • Several new antibiotics have been developed, primarily targeting multidrug-resistant Gram-positive bacteria, with some activity against Gram-negative bacteria and anaerobes.
  • Variable clinical experience exists with these agents in SSSIs, with limited specific data for DFI.
  • Some new antibiotics possess characteristics suggesting potential utility in DFI management.

Conclusions:

  • New antibiotics offer potential therapeutic options for managing SSSIs, including those in diabetic patients.
  • Further research and clinical data are needed to establish the definitive role of these agents in DFI treatment.
  • Careful consideration of spectrum of activity and pharmacological properties is crucial for selecting appropriate new antibiotics for DFI.

Related Concept Videos

Diabetic Foot Ulcer01:31

Diabetic Foot Ulcer

Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...